INmune Bio A No-Brainer Investment
The Good Brigade/DigitalVision via Getty Images
INmune Bio’s September 2021 news for XPro
I am very bullish about INmune Bio (INMB). I first reported on INmune Bio in July 2021 in view of their upcoming Alzheimer’s disease (AD) readout with their drug…
